Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Real-time Estimate Cboe BZX Other stock markets 10:52:10 2024-04-26 am EDT			5-day change	1st Jan Change
131.1 ^USD	+0.31%		+4.46%	+20.51%

04:48pm	Guggenheim Adjusts Price Target on Merck to $146 From $144	MT
04:37pm	Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guggenheim Adjusts Price Target on Merck to $146 From $144	10:48am	MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	10:37am	MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135	10:31am	MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140	10:30am	MT
Goldman Sachs Raises Price Target on Merck & Company to $144 From $139	10:13am	MT
Leerink Partners Raises Price Target on Merck & Company to $136 From $132	09:14am	MT
Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating	07:44am	MT
Jefferies Adjusts Merck & Company Price Target to $150 From $145	07:19am	MT
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating	Apr. 25	MT
BMO Capital Adjusts Price Target on Merck & Company to $148 From $132	Apr. 19	MT
Leerink Partners Raises Merck's Price Target to $134 From $129	Apr. 19	MT
Zacks Adjusts Price Target on Merck & Company to $132 From $128	Apr. 15	MT
Berenberg Raises Price Target on Merck & Company to $143 From $140, Maintains Buy Rating	Apr. 08	MT
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating	Mar. 27	MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating	Mar. 27	MT
Societe Generale Downgrades Merck to Sell From Hold, Raises Price Target to $104 From $103	Mar. 11	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04
UBS Adjusts Merck & Co.'s Price Target to $148 From $135, Maintains Buy Rating	Feb. 02	MT
Wells Fargo Raises Merck's Price Target to $130 From $125, Maintains Equalweight Rating	Feb. 02	MT
Truist Securities Raises Merck's Price Target to $139 From $122, Maintains Buy Rating	Feb. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Analyst Reco.

Filters